CAPITAL INTERNATIONAL LTD /CA/
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1065350
LOS ANGELES, CA
Position in REGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$10,515,630
+$10,480 QoQ
Shares Held
13,610
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPITAL INTERNATIONAL LTD /CA/ holds $119,458,337 across 7 Biotechnology names. REGN ranks #4 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
95,874 | $42,811,575 | |
| 2 | RPRX |
Royalty Pharma plc
|
570,577 | $27,370,578 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
76,515 | $22,722,659 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
13,610 | $10,515,630 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,078 | $9,621,037 | |
| 6 | ASND |
Ascendis Pharma A/S
|
16,394 | $3,749,799 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
56,066 | $2,667,059 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,515,630 | 13,610 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $10,505,150 | 13,610 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $15,694,080 | 27,912 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $17,803,275 | 33,911 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $27,368,292 | 43,152 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $29,182,735 | 40,968 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $37,603,906 | 35,771 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $36,548,517 | 34,774 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $29,868,952 | 31,033 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $21,101,795 | 24,026 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $19,390,583 | 23,562 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $20,383,542 | 28,368 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $25,707,589 | 31,287 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $23,009,037 | 31,891 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $22,380,697 | 32,489 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $17,168,188 | 29,043 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $19,315,503 | 27,656 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $15,462,767 | 24,485 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $14,754,893 | 24,381 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,778,623 | 24,669 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $12,210,797 | 25,808 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $13,731,918 | 28,424 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $15,732,616 | 28,105 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $14,532,292 | 23,302 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $11,507,042 | 23,566 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||